# Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer

> **NCT04516681** · PHASE3 · RECRUITING · sponsor: **Fudan University** · enrollment: 400 (estimated)

## Conditions studied

- Colorectal Cancer
- Vitamin C
- GLUT3

## Interventions

- **DRUG:** Ascorbic acid
- **DRUG:** FOLFOX Protocol
- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT04516681
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04516681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04516681, "Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04516681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*